Sarah Cannon Research Institute (SCRI) is a research organization focusing on therapies for patients which include drugs that are in development. With corporate headquarters in Nashville, Tennessee, United States, it conducts community-based clinical trials in oncology, cardiology, gastroenterology, and other therapeutic areas. The current CEO is Dee Anna Smith.
SCRI accrued more than 2,500 patients to cancer trials in 2009, including more than 500 to Phase I investigational studies. Non-oncology trials accounted for nearly 1,500 additional patients for a total of almost 4,000.
Its drug development program has conducted 400+ "first-in-human" trials. SCRI has been involved in the testing and development of about 10 drugs that have been approved since 1999.
SCRI employs over 350 people and was No. 4 on NashvillePost magazine's 2010 list of the Best Employers in Middle Tennessee. In 2009 and 2010, SCRI was awarded a spot on Modern Healthcare's list of the 100 Best Places to Work in Healthcare.
referenceEver curious about what that abbreviation stands for? fullforms has got them all listed out for you to explore. Simply,Choose a subject/topic and get started on a self-paced learning journey in a world of fullforms.
Allow To Receive Free Coins Credit 🪙